Online Event
September 01-02, 2022 | Online Event
ICTM 2019

Theory and application of chinmedomics

Xi Jun Wang, Speaker at Ethnomedicine Conferences
Heilongjiang University of Chinese Medicine, China
Title : Theory and application of chinmedomics


Evaluation of the efficacy of traditional Chinese medicines (TCMs) is an important prerequisite for discovering effective substances, lead compounds, and quality markers (Q markers). At present, there is an urgent need to develop a biological language that can act as a bridge for the scientific elaboration of the efficacy of TCMs, and to further highlight the significant value of TCM. Chinese medicinal formulae and syndromes are two essential parts of TCM that directly relate to its efficacy. Syndromes and formulae have been taken as the research objects of our team. We have integrated the serum pharmacochemistry of the TCM approach with metabolomics and established an innovative chinmedomics strategy, which is able to explore syndrome biomarkers and evaluate TCM efficacy in order to discover effective substances from TCMs. Chinmedomics approach has been widely used in identifying the candidate biomarkers of a syndrome and revealing the efficacy of the related formula in order to the discovery of lead compounds and Q markers from TCMs. We have already performed a great deal of concrete work in chinmedomics to bridge the gap between Chinese and Western medicine, and to provide a powerful approach to enhance the scientific value of TCM theory and clinical practice.


Prof. Xijun Wang, male, born in December 1961, got his pharmaceutical doctoral in Japan Hokkaido College of Pharmacy at 1998, and Chinese medicine prescription postdoctoral at 2002. Now, he is traditional Chinese medicine (TCM) professor, doctoral tutor, vice president of Heilongjiang University of Chinese Medicine, China. He mainly engaged in research on the serum pharmacochemistry of TCM, metabolomics and chinmedomics. In early 1990s, he established the theory and method of serum pharmacochemistry of TCM. In the 21st century, he integrated serum pharmacochemistry of TCM with metabolomics technology, developed chinmedomics research strategy which made contributions in solving the key scientific issues on the discovery of syndrome/disease biomarkers, the effectiveness and safety of TCM. He has published more than 350 academic papers more than 220 SCI papers, such as MCP, Hepatology, Mass Spectrom Rev, and other well-known international journals, cited 10000 times, H index 55, and 30 papers selected as ‘ESI global highly cited papers’. His research work has been recommended as special topics or highlights by Nature, F1000, RSC and other international academic institutions, and received that positive evaluation from international counterparts